Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia
Clinical trial NCT07657793 · RECRUITING
Trial details
- NCT number
- NCT07657793
- Sponsor
- Chinese SLE Treatment And Research Group
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-07
- Primary completion
- 2027-09-30
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.